Nabsys – Back from the Dead Under Bready’s Return

Kate Nagle, GoLocal News Editor

Nabsys – Back from the Dead Under Bready’s Return

Barrett Bready
Providence based start-up Nabsys announced Thursday that it completed financial restructuring under founding CEO Barrett Bready, after it shuttered its doors last fall as originally reported by GoLocal.
Bready was tight-lipped, however, on the current financial status of the company, and his investment, if any — as well as on the status of the original investments by the state’s Slater Fund and Point Judith Capital.
Nabsys had originally raised over $50 million according to Bready, including millions from Governor Raimondo’s Point Judith Capital (she continues to have an ownership in a Point Judith Fund) as well as nearly $1 million from the State of Rhode Island via the Slater Fund. 

READ: GoLocal’s Q&A with Bready BELOW

Bready, who had been CEO of Nabsys from 2005 to 2014 and helped develop the company's high definition electronic DNA mapping platform, said that in early 2015 “the company pivoted to a different and ultimately unsuccessful technical approach” under different leadership, which led to its temporary collapse — before documents secured by GoLocal showed that it was sold to Bready for $500,000 and the assumption of $100,000 in debt with General Electric Capital in December 2015.  

GET THE LATEST BREAKING NEWS HERE -- SIGN UP FOR GOLOCAL FREE DAILY EBLAST

Read More about Governor Raimono’s Ties to Nabsys — and the Slater Fund -- HERE

GoLocal's One-on-One Interview With Bready

1. Why did you restart the company?

BREADY: We restarted it in October.  Look, Nabsys has developed an incredibly powerful technology.  If you heard about how the cost of the human genome has come down —  Nabsys tells you how they’re put together, it’s called structural variation.  So we make semiconductor based devices, things that look like chips, in our case DNA molecules are flowing through those chips and we’re able to read single DNA molecules and read really long DNA molecules. The latter, we can see how the puzzle is put together. 

Will relocate to the previous location on Clifford Street
So that’s what we set out to do, but in my estimation, after I left, it took a strategic direction I wouldn’t have done.  So continuing along this analogy of it being how to put the puzzle together, after I left, the company decided to focus on the details of the puzzle pieces not how it all went together. 

So from my perspective, we were able to preserve that $65 million of investment. Every person I asked to came back came back. There are 12 of us now — there have been 12 of us since October, so they’re committed to develop the technology.

[GoLocal] was the first one to realize something had happened back in October, and it had all already happened by then. I can’t comment on the details of it.

2.  How much capital are you personally putting in, where’s the rest coming from?

BREADY: I can’t say how much capital I’m putting in.  So I teach a course in biotech management at Brown — I have students read The Billion Dollar Molecule.  In there there's a part about what it’s like to work in biotechnology startup, and the great thing about the biotechnology is the presumption of secrecy. 

So all I can say is that $65 million investment we brought in mostly from out of the state, we created a valuable product. Had too much time passed, we couldn't have moved forward. We preserved the assets and the knowledge.  We’ve got Oliver, and Nurenberg, and others.

3.  Why did the company fail the first time?

BREADY: I wouldn’t say it failed. So very little time or money was spent in ways that are not useful to us now.  It’s a useful technology — there wasn’t a problem with that instrument or process.

4.  You spent in excess of $50 million — what happened?  Why do you think this time will be successful?

BREADY: Again, it’s important to think about the way impacted the state, with the jobs it had and what we’ve done. From that perspective, it’s done well for the state, it was $65M well done so far. 

5.  How were the state of RI’s interests protected? What is Slater Fund's interest in the new company — dollar amount? How is memorialized? Warrants?  Equity?  Or debt?

BREADY: I can’t comment on the cap tables.  Keep in mind as you think about RI and their interests — 97% of the money that came into Nabsys was from out of state.  I can’t comment on the cap table.  
Again, it’s important to think about the way it’s done well for the state, it was $65M that has performed so far.


Rhode Island’s 50 Wealthiest and Most Influential - 2015 Edition

Enjoy this post? Share it with others.